{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:14:16Z","timestamp":1781788456294,"version":"3.54.5"},"reference-count":135,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014813","name":"Arizona Alzheimer's Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG14449"],"award-info":[{"award-number":["P01AG14449"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG081286"],"award-info":[{"award-number":["RF1AG081286"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG061566"],"award-info":[{"award-number":["RF1AG061566"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["CA2018010"],"award-info":[{"award-number":["CA2018010"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG068054"],"award-info":[{"award-number":["U19AG068054"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG066519"],"award-info":[{"award-number":["P30AG066519"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS087121"],"award-info":[{"award-number":["NS087121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.isci.2025.113041","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:03:39Z","timestamp":1751429019000},"page":"113041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cholinotrophic basal forebrain connectome dysfunction in Down syndrome with and without dementia"],"prefix":"10.1016","volume":"28","author":[{"given":"Marta","family":"Moreno-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4438-7334","authenticated-orcid":false,"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113041_bib1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1474-4422(10)70112-5","article-title":"Cognitive deficits and associated neurological complications in individuals with Down's syndrome","volume":"9","author":"Lott","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.isci.2025.113041_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome","volume":"17","author":"Bittles","year":"2007","journal-title":"Eur. J. Publ. Health"},{"key":"10.1016\/j.isci.2025.113041_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1567205012999151021102914","article-title":"The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective","volume":"13","author":"Salehi","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.isci.2025.113041_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in Down syndrome: unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib6","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.12659\/MSM.893377","article-title":"Delays in Motor Development in Children with Down Syndrome","volume":"21","author":"Malak","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.isci.2025.113041_bib7","series-title":"International Review of Research in Mental Retardation","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0074-7750(08)00004-9","article-title":"Chapter 4 Alzheimer\u2019s Disease in Adults with Down Syndrome","author":"Zigman","year":"2008"},{"key":"10.1016\/j.isci.2025.113041_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.35.7.957","article-title":"Alzheimer's disease in Down's syndrome: clinicopathologic studies","volume":"35","author":"Wisniewski","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2025.113041_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","article-title":"Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome","volume":"17","author":"Wisniewski","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(89)90019-1","article-title":"The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome","volume":"89","author":"Mann","year":"1989","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.isci.2025.113041_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.2301","article-title":"National population-based estimates for major birth defects, 2016-2020","volume":"116","author":"Stallings","year":"2024","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.isci.2025.113041_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1192\/bjp.180.5.405","article-title":"Genetic and host factors for dementia in Down\u2019s syndrome","volume":"180","author":"Schupf","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.isci.2025.113041_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0074-7750(08)00004-9","article-title":"Alzheimer\u2019s Disease in Adults with Down Syndrome","volume":"36","author":"Zigman","year":"2008","journal-title":"Int. Rev. Res. Ment. Retard."},{"key":"10.1016\/j.isci.2025.113041_bib14","first-page":"237","article-title":"Alzheimer\u2019s disease in Down syndrome: neurobiology and risk","volume":"13","author":"Zigman","year":"2007","journal-title":"Ment Retard Disabil Res Rev"},{"key":"10.1016\/j.isci.2025.113041_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-019-01965-6","article-title":"Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia","volume":"137","author":"Perez","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.isci.2025.113041_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1017\/S0033291798007417","article-title":"A four year prospective study of age-related cognitive change in adults with Down's syndrome","volume":"28","author":"Oliver","year":"1998","journal-title":"Psychol. Med."},{"key":"10.1016\/j.isci.2025.113041_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1352\/0895-8017(2002)107<0161:IATPOA>2.0.CO;2","article-title":"Incidence and temporal patterns of adaptive behavior change in adults with mental retardation","volume":"107","author":"Zigman","year":"2002","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.isci.2025.113041_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","article-title":"Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology","volume":"51","author":"Margallo-Lana","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.isci.2025.113041_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1034\/j.1399-0004.2002.620506.x","article-title":"The changing survival profile of people with Down's syndrome: implications for genetic counselling","volume":"62","author":"Glasson","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.isci.2025.113041_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.dhjo.2020.100947","article-title":"Cause of death in adults with Down syndrome in the United States","volume":"13","author":"Landes","year":"2020","journal-title":"Disabil. Health J."},{"key":"10.1016\/j.isci.2025.113041_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jar.12446","article-title":"Early death and causes of death of people with Down syndrome: A systematic review","volume":"31","author":"O'Leary","year":"2018","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"10.1016\/j.isci.2025.113041_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14479","article-title":"A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology","volume":"21","author":"Liou","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.isci.2025.113041_bib24","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1002\/alz.12999","article-title":"Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome","volume":"19","author":"Rozalem Aranha","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.isci.2025.113041_bib25","article-title":"Role of Cholinergic Signaling in Alzheimer's Disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2025.113041_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5005\/jp-journals-10005-2347","article-title":"Assessment of Knowledge, Attitude, and Practices Regarding Advanced Local Anesthetic Techniques among Students Attending a Private Dental College in Navi Mumbai, India: A Cross-sectional Study","volume":"15","author":"Bhanushali","year":"2022","journal-title":"Int. J. Clin. Pediatr. Dent."},{"key":"10.1016\/j.isci.2025.113041_bib27","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/s41467-024-46484-5","article-title":"The influence of cortical activity on perception depends on behavioral state and sensory context","volume":"15","author":"Russell","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.113041_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A","article-title":"Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease","volume":"427","author":"Mufson","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/NEN.0b013e318272caab","article-title":"Hippocampal proNGF signaling pathways and beta-amyloid levels in mild cognitive impairment and Alzheimer disease","volume":"71","author":"Mufson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib30","first-page":"237","article-title":"Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome","volume":"4","author":"Mufson","year":"1993","journal-title":"Dementia"},{"key":"10.1016\/j.isci.2025.113041_bib31","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.isci.2025.113041_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cne.902140206","article-title":"Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey","volume":"214","author":"Mesulam","year":"1983","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0896-6273(03)00266-6","article-title":"Evidence in support of signaling endosome-based retrograde survival of sympathetic neurons","volume":"39","author":"Ye","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2025.113041_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnins.2019.00062","article-title":"The Brain NGF Metabolic Pathway in Health and in Alzheimer's Pathology","volume":"13","author":"Cuello","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/alz.12229","article-title":"Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study","volume":"17","author":"Pentz","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.isci.2025.113041_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8445093","article-title":"Nerve Growth Factor (NGF) Encourages the Neuroinvasive Potential of Pancreatic Cancer Cells by Activating the Warburg Effect and Promoting Tumor Derived Exosomal miRNA-21 Expression","volume":"2022","author":"Peng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2025.113041_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1073\/pnas.83.3.817","article-title":"Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system","volume":"83","author":"Whittemore","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113041_bib38","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1073\/pnas.83.8.2714","article-title":"Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons","volume":"83","author":"Shelton","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113041_bib39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0306-4522(94)90291-7","article-title":"Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus","volume":"59","author":"Salehi","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.isci.2025.113041_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cne.903410407","article-title":"Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation","volume":"341","author":"Mufson","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib41","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/j.1460-2075.1985.tb03791.x","article-title":"Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation","volume":"4","author":"Korsching","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2025.113041_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib43","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ajpath.2011.07.044","article-title":"Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease","volume":"179","author":"Vana","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2025.113041_bib44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajpath.2011.10.027","article-title":"Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease","volume":"180","author":"Perez","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2025.113041_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.tips.2014.04.010","article-title":"Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome","volume":"35","author":"Iulita","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2025.113041_bib46","series-title":"The Neurobiology of Aging and Alzheimer Disease in Down Syndrome","first-page":"11","article-title":"Chapter 2 - Alzheimer's neuropathology in Down syndrome: From gestation to old age","author":"Mufson","year":"2022"},{"key":"10.1016\/j.isci.2025.113041_bib47","first-page":"291","article-title":"Role of Nerve Growth Factor in Plasticity of Forebrain Cholinergic Neurons","volume":"82","author":"Isaev","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2025.113041_bib48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1471-4159.2004.02908.x","article-title":"Regulation of cholinergic gene expression by nerve growth factor depends on the phosphatidylinositol-3'-kinase pathway","volume":"92","author":"Madziar","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.isci.2025.113041_bib49","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fnins.2019.00533","article-title":"Nerve Growth Factor Pathobiology During the Progression of Alzheimer's Disease","volume":"13","author":"Mufson","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1471-4159.2006.03764.x","article-title":"Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease","volume":"97","author":"Ginsberg","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.isci.2025.113041_bib51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.20233","article-title":"Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease","volume":"56","author":"Counts","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib53","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.64.9.1312","article-title":"Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease","volume":"64","author":"Ikonomovic","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib54","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/alz.13692","article-title":"Down Syndrome Biobank Consortium: A perspective","volume":"20","author":"Aldecoa","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.isci.2025.113041_bib55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00005072-199409000-00011","article-title":"Development of the superior temporal neocortex is anomalous in trisomy 21","volume":"53","author":"Golden","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-022-01385-w","article-title":"Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome","volume":"10","author":"Utagawa","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.isci.2025.113041_bib57","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/hbm.24230","article-title":"Down syndrome is accompanied by significantly reduced cortical grey-white matter tissue contrast","volume":"39","author":"Bletsch","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.isci.2025.113041_bib58","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1176\/appi.ajp.158.10.1659","article-title":"Neuroanatomy of Down's syndrome: a high-resolution MRI study","volume":"158","author":"Pinter","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.isci.2025.113041_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/hipo.20308","article-title":"Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice","volume":"17","author":"Contestabile","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.isci.2025.113041_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.aanat.2008.05.007","article-title":"Reduced cell number in the neocortical part of the human fetal brain in Down syndrome","volume":"190","author":"Larsen","year":"2008","journal-title":"Ann. Anat."},{"key":"10.1016\/j.isci.2025.113041_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0301-0082(98)00059-8","article-title":"Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases","volume":"57","author":"Mufson","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.isci.2025.113041_bib62","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.113041_bib63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.113041_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cne.902690112","article-title":"Morphological response of axotomized septal neurons to nerve growth factor","volume":"269","author":"Gage","year":"1988","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib65","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0896-6273(94)90470-7","article-title":"Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC12 cells","volume":"13","author":"Barker","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2025.113041_bib67","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0896-6273(92)90066-M","article-title":"Nerve growth factor mediates signal transduction through trk homodimer receptors","volume":"9","author":"Jing","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2025.113041_bib68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1523\/JNEUROSCI.15-01-00477.1995","article-title":"Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins","volume":"15","author":"Shelton","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib69","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.onc.1201842","article-title":"Specific TrkA survival signals interfere with different apoptotic pathways","volume":"16","author":"Ulrich","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.113041_bib70","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1046\/j.1471-4159.2000.741185.x","article-title":"Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome","volume":"74","author":"Sendera","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.isci.2025.113041_bib71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/(SICI)1096-9861(19990906)411:4<693::AID-CNE13>3.0.CO;2-D","article-title":"Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease","volume":"411","author":"Gilmor","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib72","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cne.10122","article-title":"Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer\u2019s disease","volume":"443","author":"Mufson","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2019.00129","article-title":"ProNGF and Neurodegeneration in Alzheimer's Disease","volume":"13","author":"Fahnestock","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib74","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0736-5748(98)00088-4","article-title":"NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease","volume":"16","author":"Hellweg","year":"1998","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib75","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0955-0674(97)80065-8","article-title":"Signal transduction by the neurotrophin receptors","volume":"9","author":"Kaplan","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.isci.2025.113041_bib76","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1126\/science.8332899","article-title":"Induction of apoptosis by the low-affinity NGF receptor","volume":"261","author":"Rabizadeh","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.113041_bib77","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.277.5329.1097","article-title":"An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons","volume":"277","author":"Riccio","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.113041_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.conb.2005.01.004","article-title":"p75NTR--live or let die","volume":"15","author":"Nykjaer","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.isci.2025.113041_bib79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00001756-199505090-00028","article-title":"Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis","volume":"6","author":"Mufson","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.isci.2025.113041_bib80","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1073\/pnas.89.2.569","article-title":"Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease","volume":"89","author":"Mufson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113041_bib81","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2001.7710","article-title":"Neuropathology of mice carrying mutant APP(swe) and\/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway","volume":"170","author":"Jaffar","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/brain\/aww271","article-title":"The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor","volume":"140","author":"Capsoni","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.isci.2025.113041_bib83","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/glia.20857","article-title":"Nerve growth factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor","volume":"57","author":"Cragnolini","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.isci.2025.113041_bib84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2007.07.020","article-title":"NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta","volume":"190","author":"De Simone","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.isci.2025.113041_bib85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phrs.2018.10.028","article-title":"Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells","volume":"139","author":"Cattaneo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2025.113041_bib86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.isci.2025.113041_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-2094-10-84","article-title":"Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113041_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/170276","article-title":"Neuroinflammation in the aging down syndrome brain; lessons from Alzheimer's disease","volume":"2012","author":"Wilcock","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"10.1016\/j.isci.2025.113041_bib89","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s004010050906","article-title":"Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma","volume":"96","author":"Wang","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.isci.2025.113041_bib90","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12974-021-02294-w","article-title":"Regulation of the p75 neurotrophin receptor attenuates neuroinflammation and stimulates hippocampal neurogenesis in experimental Streptococcus pneumoniae meningitis","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113041_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043200","article-title":"The Nerve Growth Factor Receptor (NGFR\/p75(NTR)): A Major Player in Alzheimer's Disease","volume":"24","author":"Bruno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.113041_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2019.00129","article-title":"ProNGF and Neurodegeneration in Alzheimer\u2019s Disease","volume":"13","author":"Fahnestock","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib93","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fnins.2019.00533","article-title":"Nerve Growth Factor Pathobiology During the Progression of Alzheimer\u2019s Disease","volume":"13","author":"Mufson","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib94","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer's disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.isci.2025.113041_bib95","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2016.05.030","article-title":"Molecular and cellular pathophysiology of preclinical Alzheimer's disease","volume":"311","author":"Mufson","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.isci.2025.113041_bib96","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1871527315666160321104916","article-title":"A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-beta-Driven Inflammation in Down Syndrome","volume":"15","author":"Iulita","year":"2016","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.isci.2025.113041_bib97","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1460-9568.2008.06152.x","article-title":"Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system","volume":"27","author":"Al-Shawi","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib98","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0169-328X(96)00193-3","article-title":"Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex","volume":"42","author":"Fahnestock","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.isci.2025.113041_bib99","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1471-4159.2004.02360.x","article-title":"The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor","volume":"89","author":"Fahnestock","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.isci.2025.113041_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030599","article-title":"ProNGF, but Not NGF, Switches from Neurotrophic to Apoptotic Activity in Response to Reductions in TrkA Receptor Levels","volume":"18","author":"Ioannou","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.113041_bib101","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0002-9440(10)62275-4","article-title":"Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR","volume":"166","author":"Pedraza","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2025.113041_bib102","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jnen\/63.6.641","article-title":"Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease","volume":"63","author":"Peng","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib103","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/mcne.2001.1016","article-title":"The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease","volume":"18","author":"Fahnestock","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.isci.2025.113041_bib104","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/brain\/awt372","article-title":"Nerve growth factor metabolic dysfunction in Down's syndrome brains","volume":"137","author":"Iulita","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.isci.2025.113041_bib105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1567205012666150921100030","article-title":"The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease","volume":"13","author":"Iulita","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.isci.2025.113041_bib106","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","article-title":"Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease","volume":"68","author":"Bruno","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib107","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/NEN.0b013e3181c22569","article-title":"Increased matrix metalloproteinase 9 activity in mild cognitive impairment","volume":"68","author":"Bruno","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib108","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI82409","article-title":"Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration","volume":"126","author":"Xu","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.113041_bib109","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.isci.2025.113041_bib110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/13872877241297382","article-title":"Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomography","volume":"102","author":"Suzuki","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.isci.2025.113041_bib111","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jnen\/nlx120","article-title":"Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease","volume":"77","author":"Tiernan","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib112","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neurobiolaging.2016.02.031","article-title":"Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease","volume":"42","author":"Tiernan","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.isci.2025.113041_bib113","doi-asserted-by":"crossref","first-page":"15219","DOI":"10.1074\/jbc.M115.645507","article-title":"Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE","volume":"290","author":"Jin","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.113041_bib114","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.113041_bib115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/NEN.0b013e318202bfa1","article-title":"Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome","volume":"70","author":"Wegiel","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib116","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.neurobiolaging.2004.08.005","article-title":"Alzheimer disease and Down syndrome: factors in pathogenesis","volume":"26","author":"Lott","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.isci.2025.113041_bib117","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1091\/mbc.e04-12-1085","article-title":"DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1","volume":"16","author":"Kelly","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.isci.2025.113041_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004606","article-title":"Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A","volume":"4","author":"Guedj","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113041_bib119","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1742-4658.2010.07954.x","article-title":"MNB\/DYRK1A as a multiple regulator of neuronal development","volume":"278","author":"Tejedor","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2025.113041_bib120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-8628(19990625)89:2<100::AID-AJMG8>3.0.CO;2-N","article-title":"Health care concerns and guidelines for adults with Down syndrome","volume":"89","author":"van Allen","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.isci.2025.113041_bib121","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1192\/bjp.161.5.722a","article-title":"Longevity and Down's syndrome","volume":"161","author":"Prasher","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.isci.2025.113041_bib122","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down's syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib123","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2788.2007.00985.x","article-title":"The prevalence and incidence of mental ill-health in adults with Down syndrome","volume":"52","author":"Mantry","year":"2008","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.isci.2025.113041_bib124","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1352\/0047-6765(1997)035<0477:LOAWWD>2.0.CO;2","article-title":"Longevity of a woman with Down syndrome: a case study","volume":"35","author":"Chicoine","year":"1997","journal-title":"Ment. Retard."},{"key":"10.1016\/j.isci.2025.113041_bib125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcb.240220404","article-title":"A comparison of binding properties and structure of NGF receptor on PC12 pheochromocytoma and A875 melanoma cells","volume":"22","author":"Buxser","year":"1983","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.isci.2025.113041_bib126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0092-8674(86)90619-7","article-title":"Expression and structure of the human NGF receptor","volume":"47","author":"Johnson","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113041_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606861","article-title":"Tissue-Specificity of Antibodies Raised Against TrkB and p75(NTR) Receptors; Implications for Platelets as Models of Neurodegenerative Diseases","volume":"12","author":"Fleury","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113041_bib128","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/gps.4228","article-title":"Dementia diagnostic criteria in Down syndrome","volume":"30","author":"Sheehan","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.isci.2025.113041_bib129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-020-1723-x","article-title":"Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease","volume":"17","author":"Moreno-Rodriguez","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2025.113041_bib130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3233\/JAD-2012-120115","article-title":"Hippocampal membrane-associated p75NTR levels are increased in Alzheimer's disease","volume":"30","author":"Chakravarthy","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.isci.2025.113041_bib131","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cne.902850204","article-title":"Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons","volume":"285","author":"Mufson","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib132","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-4886(89)90124-6","article-title":"Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain","volume":"105","author":"Mufson","year":"1989","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.isci.2025.113041_bib133","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1023\/A:1020952704398","article-title":"Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease","volume":"27","author":"Mufson","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.isci.2025.113041_bib134","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0891-0618(03)00068-1","article-title":"Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction","volume":"26","author":"Mufson","year":"2003","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.isci.2025.113041_bib135","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/nan.12518","article-title":"HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease","volume":"45","author":"Mahady","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225013021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225013021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:11:00Z","timestamp":1771380660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225013021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":135,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2589004225013021"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113041","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholinotrophic basal forebrain connectome dysfunction in Down syndrome with and without dementia","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113041"}}